List of insiders holdings for Aprea Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | HealthCap VII L.P. HealthCap VII GP S.A. 10% Owner |
2022-11-15 17:08:05 | 2,366,104 0 |
2,366,104 | Form 13D |
| 2 | KDev Investments AB Karolinska Development AB KCIF Co-Investment Fund KB 10% Owner |
2021-02-16 06:51:58 | 1,780,691 0 |
1,780,691 | Form 13G |
| 3 | 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Partners IV LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC DIEKMAN JOHN D Schwab Andrew J. PARMAR KUSH ROCKLAGE SCOTT M Former 10% holder |
2021-02-16 17:08:15 | 619,157 0 |
619,157 | Form 13D |
| 4 | Gilad Oren President/CEO |
2025-04-04 07:30:11 | 345,620 1,800 |
347,420 | Form 4 |
| 5 | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner |
2020-05-20 21:58:59 | 333,333 6,968 |
340,301 | Form 4 |
| 6 | SCHADE CHRISTIAN S Director |
2022-08-01 17:06:17 | 306,846 11,000 |
317,846 | Form 4 |
| 7 | Coiante Scott M SVP, Chief Financial Officer |
2022-08-01 17:00:42 | 234,265 0 |
234,265 | Form 4 |
| 8 | Duey Marc Director |
2024-10-25 17:42:04 | 233,651 602 |
234,253 | Form 4 |
| 9 | Abrahmsen Lars B. SVP, Chief Scientific Officer |
2022-03-14 17:01:04 | 143,700 0 |
143,700 | Form 4 |
| 10 | Wessels Gregory S. SVP, Chief Commercial Officer |
2021-03-01 19:10:17 | 82,000 0 |
82,000 | Form 4 |
| 11 | Korbel Gregory Alan SVP, Chief Operating Officer |
2022-08-01 17:04:13 | 81,462 0 |
81,462 | Form 4 |
| 12 | Attar Eyal C. SVP, Chief Medical Officer |
2022-06-07 17:00:32 | 57,233 331 |
57,564 | Form 4 |
| 13 | Seizinger Bernd R. Director |
2024-10-15 08:31:44 | 44,730 0 |
44,730 | Form 4 |
| 14 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr |
2025-03-31 16:31:29 | 36,193 0 |
36,193 | Form 4 |
| 15 | Mirza Nadeem Q. Chief Medical Officer |
2024-05-02 16:16:29 | 33,650 0 |
33,650 | Form 4 |
| 16 | Namouni Fouad Director |
2021-07-01 18:58:01 | 27,360 0 |
27,360 | Form 4 |
| 17 | Kelly Michael Aaron Director |
2021-07-01 19:07:34 | 27,360 0 |
27,360 | Form 4 |
| 18 | Pamukcu Rifat Director |
2024-06-21 16:19:20 | 8,586 14,108 |
22,694 | Form 4 |
| 19 | HENNEMAN JOHN B III Director |
2024-06-21 16:17:29 | 13,369 0 |
13,369 | Form 4 |
| 20 | Gruia Gabriela Director |
2023-05-08 17:17:19 | 12,500 0 |
12,500 | Form 4 |
| 21 | BIZZARI JEAN-PIERRE Director |
2023-08-24 21:47:00 | 12,500 0 |
12,500 | Form 4 |
| 22 | Magni Guido Director |
2019-10-07 19:25:54 | 6,500 0 |
6,500 | Form 4 |
| 23 | Peters Richard Director |
2024-06-21 16:18:13 | 6,259 0 |
6,259 | Form 4 |
| 24 | Grissinger Michael Director |
2024-06-21 16:16:34 | 6,029 0 |
6,029 | Form 4 |
| 25 | Hepple Jonathan Director |
2020-07-01 18:03:19 | 5,600 0 |
5,600 | Form 4 |
| 26 | Christenson Johan Director |
2020-07-01 18:01:06 | 5,600 0 |
5,600 | Form 4 |
| 27 | Redmile Group LLC Green Jeremy 10% Owner |
2022-02-14 17:07:14 | 0 0 |
0 | Form 13G |
| 28 | Versant V Luxco S.a r.l. Versant Venture Capital V L.P. Versant Affiliates Fund V L.P. Versant Ophthalmic Affiliates I L.P. Versant Venture Capital V (Canada) LP Versant Ventures V LLC Versant Ventures V (Canada) L.P. 10% Owner |
2022-02-10 20:44:54 | 0 0 |
0 | Form 13G |
| 29 | Versant V Luxco S.a r.l. Versant Ventures V LLC Versant Ventures V GP-GP (Canada) Inc. Versant Ventures V (Canada) L.P. Versant Venture Capital V (Canada) LP Versant Affiliates Fund V L.P. Versant Ophthalmic Affiliates I L.P. Versant Venture Capital V L.P. 10% Owner |
2022-02-10 20:44:54 | 0 0 |
0 | Form 13G |